
Wall Street Journal - November 21, 2003
Marilyn Chase and Betsy Mckay, Staff Reporters of The Wall Street Journal
Syphilis cases among men rose more than 27%, with the largest increase -- more than 85% -- seen in white men. Cases rose more than 35% in Latino men, and declined 2.6% in African-American men.
Still, the highest rates of the disease remain among African-American men -- 13.5 per 100,000 population -- compared with 4.5 among Latino men and 2.2 among non-Hispanic whites.
Female case reports were a bright spot: Syphilis cases declined 19% among women overall, and almost 22% among African-American women.
The syphilis surge among American males is believed to stem largely from the rise in unprotected sex among gay and bisexual men, the CDC said. The agency doesn't collect data by sexual orientation, but said its researchers estimated 40% of syphilis cases in 2002 occurred among men who have sex with men.
Ronald O. Valdiserri, deputy director of the CDC's HIV, sexually transmitted diseases and TB prevention center, said a battle is now being waged on two fronts: sustaining reductions in syphilis among women and African-Americans, while "combating new challenges among gay and bisexual men."
John Douglas, director of the CDC's sexually transmitted disease prevention programs, cited relaxation of safe sexual behavior owing to the widespread belief that HIV is under control. Substance abuse, depression and other factors may play a role, he said.
In San Francisco, city health officers have conducted an information campaign for two years on the Web and in bus shelters, advertising syphilis testing and treatment services.
"We saw this coming," said Steve Gibson, who manages the Magnet, a gay men's health clinic in the city's Castro District.
Officials worry that the increase portends a resurgence of HIV infection; studies have shown that syphilis can facilitate HIV transmission.
Write to Marilyn Chase at marilyn.chase@wsj.com and Betsy McKay at betsy.mckay@wsj.com
031121
WJ031106
Copyright © 2003 - The Wall Street Journal. Reproduction of this article (other than one copy for personal reference) must be cleared through the WSJ Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .